Evidence map›Paper›PMID 25083491›Full record

ReviewGland surgery2014

Primary and secondary angiosarcoma of the breast.

Tania K Arora, Krista P Terracina, John Soong, Michael O Idowu, Kazuaki Takabe

Open access · greenAbstract readReview
In one paragraph

Review in Gland surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Recurrent radiogenic angiosarcoma of the breast: a rare case report.International journal of surgery case reports · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Article
  11. Recurrent Breast Angiosarcoma.Kansas journal of medicine · 2023
    Article
  12. Primary Breast Angiosarcoma: Comparative Transcriptome Analysis.International journal of molecular sciences · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tania K Arora1 Division of Surgical Oncology, Department of Surgery, 2 Department of Pathology, Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA 23298-0011, USA.
Krista P Terracina1 Division of Surgical Oncology, Department of Surgery, 2 Department of Pathology, Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA 23298-0011, USA.
John Soong1 Division of Surgical Oncology, Department of Surgery, 2 Department of Pathology, Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA 23298-0011, USA.
Michael O Idowu1 Division of Surgical Oncology, Department of Surgery, 2 Department of Pathology, Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA 23298-0011, USA.
Kazuaki Takabe1 Division of Surgical Oncology, Department of Surgery, 2 Department of Pathology, Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA 23298-0011, USA.
Virginia Commonwealth University · US

Funding

POSTDOCTORAL TRAINING PROGRAM IN CANCER BIOLOGYT32CA085159 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI GINDER, GORDON D · 2000 to 2011
$2.0M
Sphingosine-1 Phosphate in Breast Cancer Progression and LymphangiogenesisR01CA160688 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI TAKABE, KAZUAKI · 2012 to 2016
$1.5M
NCI NIH HHS R01 CA160688NCI NIH HHS T32 CA085159
6 · The paper itself

Abstract

Angiosarcoma is a rare soft tissue tumor of the breast. It occurs in both a primary form without a known precursor, and a secondary form that has been associated to a history of irradiated breast tissue. These forms differ in many ways including median age, precipitating factors, and presentation. Both forms have a malignant behavior and a poor prognosis. The endeavor of this paper is to review what is known about the presentation, diagnostic and therapeutic modalities to date.

Indexed as

aggressiveBreastcancerradiationrapid growth

Identifiers

PMID25083491
PMCPMC4115777
OpenAlexW147255264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.